Apremilast Tablets 30 Mg – Oral PDE4 Inhibitor for Chronic Inflammatory Skin and Joint Disorders.
REMILOR 30 Tablets: The composition of Apremilast 30 mg is a selective phosphodiesterase-4 (PDE4) inhibitor. It helps control chronic inflammatory conditions such as psoriasis and psoriatic arthritis by regulating intracellular cAMP levels, thereby reducing inflammation and the severity of skin lesions. It is considered safe and well-tolerated, even for long-term therapy.
Recommended by Specialists
✅Dermatologists: Commonly prescribe for plaque psoriasis
✅Rheumatologists: It is prescribed for psoriatic arthritis
Key Benefits of Apremilast Tablets 30 Mg – REMILOR 30 Tablets:
✅Precise Anti-Inflammatory Effect – Blocks PDE4, lowering pro-inflammatory cytokines like TNF-α, IL-17, and IL-23.
✅Steroid-Sparing Oral Option – Beneficial in moderate-to-severe psoriasis and psoriatic arthritis without the risks of broad immunosuppression.
✅Good Safety Profile: Requires minimal laboratory monitoring and has a low risk of severe adverse effects.
Indications
✅Chronic Plaque Psoriasis
✅Psoriatic Arthritis
✅Oral Ulcers Associated with Behçet’s Disease
✅Alternative to Steroids or DMARDs
✅Long-term management of psoriasis